Company news

Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) news

Every Amphastar Pharmaceuticals, Inc. press release and news update in one place — announcements, filings coverage, and company updates for investors.

Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) news

Press releases & updates

Amphastar Pharmaceuticals to Release Second Quarter Earnings and Hold Conference Call on August 6, 2026

Amphastar Pharmaceuticals to Present at the 2026 Jefferies Healthcare Conference

Amphastar Pharmaceuticals : Q1 Financial Results (news)

Amphastar Pharmaceuticals Reports Financial Results for the Three Months Ended March 31, 2026

Amphastar Pharmaceuticals to Present at the 2026 Bank of America Health Care Conference

Amphastar Pharmaceuticals to Release First Quarter Earnings and Hold Conference Call on May 7, 2026

Amphastar Pharmaceuticals to Present at the 25th Annual Needham Healthcare Conference

Amphastar Pharmaceuticals to Present at the Barclays 28th Annual Global Healthcare Conference

Amphastar Pharmaceuticals Reports Financial Results for the Three Months and Full Year Ended December 31, 2025

Amphastar Announces FDA Approval for Ipratropium Bromide HFA

Amphastar Pharmaceuticals to Release Fourth Quarter Earnings and Hold Conference Call on February 26, 2026

Amphastar Pharmaceuticals Announces Exclusive License Agreement with Nanjing Hanxin Pharmaceutical Technology Co., Ltd. for Fully Synthet...

Amphastar Pharmaceuticals to Present at the J.P. Morgan 2026 Healthcare Conference

Amphastar Announces FDA Approval for Teriparatide Injection

Amphastar Pharmaceuticals to Present at the 37th Annual Piper Sandler Healthcare Conference

Amphastar Pharmaceuticals : Q1 Financial Results (AMP 2025 Q1 Earnings Release FINAL)

Amphastar Pharmaceuticals : Q2 Financial Results (AMP 2025 Q2 Earnings Release FINAL)

Amphastar Pharmaceuticals : Q3 Financial Results (AMP 2025 Q3 Earnings Release FINAL)

Amphastar Pharmaceuticals to Present at the Jefferies Global Healthcare Conference

Amphastar Pharmaceuticals Reports Financial Results for the Three Months Ended September 30, 2025

Amphastar Pharmaceuticals to Release Third Quarter Earnings and Hold Conference Call on November 6th, 2025

Amphastar Pharmaceuticals to Present at the 2025 Wells Fargo Healthcare Conference

Amphastar Pharmaceuticals Bolsters Proprietary Pipeline Through Exclusive Licensing Agreement with Nanjing Anji Biotechnology Co., Ltd.

Amphastar Announces FDA Approval for Iron Sucrose Injection, USP

Amphastar Announces FDA Approval for Iron Sucrose Injection, USP

Amphastar Pharmaceuticals Reports Financial Results for the Three Months Ended June 30, 2025

Amphastar Pharmaceuticals to Release Second Quarter Earnings and Hold Conference Call on August 7th, 2025

Amphastar Pharmaceuticals Aims to Quadruple Domestic Manufacturing Capacity at Rancho Cucamonga Headquarters

Amphastar Pharmaceuticals to Present at the 2025 Bank of America Health Care Conference

Amphastar Pharmaceuticals Reports Financial Results for the Three Months Ended March 31, 2025

Amphastar Pharmaceuticals to Release First Quarter Earnings and Hold Conference Call on May 7th, 2025

Amphastar Pharmaceuticals to Present at the 24th Annual Needham Virtual Healthcare Conference

International Medication Systems, Ltd. Receives FDA's Drug Shortage Assistance Award

Amphastar Pharmaceuticals to Present at the Barclays 27th Annual Global Healthcare Conference

Amphastar Pharmaceuticals Reports Financial Results for the Three Months and Full Year Ended December 31, 2024

Amphastar Pharmaceuticals to Release Fourth Quarter Earnings and Hold Conference Call on February 27, 2025

Amphastar Pharmaceuticals to Present at the 43rd Annual J.P. Morgan Healthcare Conference

Amphastar Pharmaceuticals to Present at the 36th Annual Piper Sandler Healthcare Conference

Amphastar Pharmaceuticals to Present at the Jefferies London Healthcare Conference

Amphastar Pharmaceuticals Reports Financial Results for the Three Months Ended September 30, 2024

Amphastar Pharmaceuticals to Release Third Quarter Earnings and Hold Conference Call on November 6, 2024

Amphastar Pharmaceuticals to Present at the 2024 Wells Fargo Healthcare Conference

Amphastar Pharmaceuticals Reports Financial Results for the Three Months Ended June 30, 2024

Amphastar Pharmaceuticals to Release Second Quarter Earnings and Hold Conference Call on August 7, 2024

Amphastar Announces Additional $50 Million Increase to its Share Buyback Program

Amphastar Receives FDA Approval for Albuterol Sulfate Inhalation Aerosol

Amphastar Pharmaceuticals to Present at the Bank of America Securities Health Care Conference

Amphastar Pharmaceuticals Reports Financial Results for the Three Months Ended March 31, 2024

Amphastar Pharmaceuticals to Release First Quarter Earnings and Hold Conference Call on May 8, 2024

Amphastar Pharmaceuticals to Present at the 23rd Annual Needham Virtual Healthcare Conference